Delivery Order SPE2DB20D7066-SPE2DB25FC1QA

Award Date 11/7/24
Potential Completion Date 11/8/24
Potential Value $55K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC1QA
    Delivery Order

This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, awarded to AmerisourceBergen Drug Corporation, is a Firm Fixed Price Delivery Order with a ceiling value of $55,184.00 and an ultimate completion date of November 8, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corporation is a major pharmaceutical distributor and healthcare solutions provider that maintains significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively, for the provision of a wide range of pharmaceutical products and medical supplies to support federal healthcare programs.

Generated 2/6/25, 9:30 AM